Shamrock Medical Solutions Group LLC
Shamrock Medical Solutions Group LLC appears in FDA public data with 6 recalls — including 3 Class I (most serious) —, 0 510(k) clearances, 4 FDA inspections, and 3 compliance actions on record. Its most recent recall (D-1446-2014, Class I) was initiated on September 27, 2011.
Summary
- Total Recalls
- 6 (3 Class I)
- 510(k) Clearances
- 0
- Inspections
- 4
- Compliance Actions
- 3
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1446-2014 | Class I | Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: S | September 27, 2011 |
| D-1449-2014 | Class II | Pramipexole Dihydrochloride Tablets, 0.5 mg, Rx, packaged and labeled to contain Nebivolol tablets, | September 27, 2011 |
| D-1447-2014 | Class I | Oxycodone HCl Oral Concentrate, 20 mg/mL, Rx (C-II) Packaged and labeled as Morphine Sulfate 20 mg/m | September 27, 2011 |
| D-1451-2014 | Class II | Docusate Calcium Softgel Capsules, 240 mg, OTC, packaged and labeled to contain Docusate Sodium 240m | September 27, 2011 |
| D-1448-2014 | Class I | metFORMIN ER Tablets, 500 mg, Rx, Packaged and labeled as metFORMIN Immediate Release (IR), Repackag | September 27, 2011 |
| D-1450-2014 | Class II | Sulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg, DOUBLE STRENGTH, Rx, packaged and labeled | September 27, 2011 |